Company Filing History:
Years Active: 2004
Title: Christopher J Etheridge: Innovator in Transfection Agents
Introduction: Christopher J Etheridge is a notable inventor based in London, GB, recognized for his significant contribution to the field of biotechnology. His innovative work focuses on the development of transfection agents that have the potential to advance gene delivery systems.
Latest Patents: Etheridge holds a patent for "Polycationic sterol derivatives as transfection agents." This patent describes a unique compound capable of acting as a cationic lipid, consisting of a cholesterol group linked to a head group that is more positive than that of DC-Chol. This innovation is pivotal in enhancing the efficiency of gene transfection processes.
Career Highlights: Etheridge is associated with Ic-vec Limited, where he applies his expertise in the biotechnology sector. His involvement in this company reflects his commitment to advancing scientific research and practical applications in gene therapy and delivery.
Collaborations: In his professional journey, Etheridge has collaborated with esteemed colleagues, including Andrew David Miller and Robert G Cooper. Their teamwork exemplifies the knowledge sharing and collaborative spirit that drives innovation in the scientific community.
Conclusion: Christopher J Etheridge's contributions to the field of transfection agents through his patented work represent a significant step forward in biotechnology. As he continues to work with Ic-vec Limited and collaborate with other experts, his innovations hold promise for future advancements in gene delivery systems.